| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/AR.1092380108 |
| P698 | PubMed publication ID | 7509580 |
| P50 | author | Artur Águas | Q38544070 |
| P2093 | author name string | de Sá CM | |
| Grande NR | |||
| Peão MN | |||
| P433 | issue | 1 | |
| P921 | main subject | pulmonary fibrosis | Q32446 |
| P1104 | number of pages | 11 | |
| P304 | page(s) | 57-67 | |
| P577 | publication date | 1994-01-01 | |
| P1433 | published in | The Anatomical Record | Q2725967 |
| P1476 | title | Neoformation of blood vessels in association with rat lung fibrosis induced by bleomycin | |
| P478 | volume | 238 |
| Q36225646 | Abnormal deposition of collagen/elastic vascular fibres and prognostic significance in idiopathic interstitial pneumonias. |
| Q38596610 | Analysis of tumor vessel supply in Lewis lung carcinoma in mice by fluorescent microsphere distribution and imaging with micro- and flat-panel computed tomography |
| Q34882979 | Angiogenesis in interstitial lung diseases: a pathogenetic hallmark or a bystander? |
| Q90325135 | Angiogenesis in the lung |
| Q35536768 | Angiogenic cytokines in patients with idiopathic interstitial pneumonia |
| Q41703248 | Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis. |
| Q35570990 | Bleomycin-induced pulmonary toxicity in chemotherapy for testicular cancer |
| Q33756881 | CXCR3 Requirement for the Interleukin-13-Mediated Up-Regulation of Interleukin-13Rα2 in Pulmonary Fibroblasts |
| Q30426904 | Chemokines as mediators of angiogenesis. |
| Q30438032 | Chemokines as mediators of neovascularization |
| Q47117383 | Deregulated angiogenesis in chronic lung diseases: a possible role for lung mesenchymal progenitor cells (2017 Grover Conference Series). |
| Q36888683 | Endostatin, an angiogenesis inhibitor, ameliorates bleomycin-induced pulmonary fibrosis in rats |
| Q38264434 | Experimental studies in the bronchial circulation. Which is the ideal animal model? |
| Q38110499 | Genetic and environmental influences on gas exchange |
| Q47714102 | Heterogeneous remodeling of lung vessels in idiopathic pulmonary fibrosis |
| Q21202895 | Idiopathic pulmonary fibrosis |
| Q36440438 | Idiopathic pulmonary fibrosis : new concepts in pathogenesis and implications for drug therapy |
| Q40753351 | Increased ocular levels of IGF-1 in transgenic mice lead to diabetes-like eye disease. |
| Q73114162 | Intraluminal fibromyxoid lesions in bronchiolitis obliterans organizing pneumonia are highly capillarized |
| Q34195733 | Kinetics of the angiogenic response in lung endothelium following acute inflammatory injury with bleomycin |
| Q28389679 | Nitric oxide mediates bleomycin-induced angiogenesis and pulmonary fibrosis via regulation of VEGF |
| Q34903224 | Novel therapeutic approaches for pulmonary fibrosis |
| Q38111715 | Physiological and pathological angiogenesis in the adult pulmonary circulation |
| Q28388425 | Pulmonary fibrosis: pathogenesis, etiology and regulation |
| Q23909818 | Pulmonary toxicity and fibrogenic response of carbon nanotubes |
| Q23918832 | Reactive oxygen species-mediated p38 MAPK regulates carbon nanotube-induced fibrogenic and angiogenic responses |
| Q36472048 | Regulation of fibrosis by the immune system |
| Q39655218 | The calpain inhibitor calpeptin prevents bleomycin-induced pulmonary fibrosis in mice |
| Q24799089 | The importance of balanced pro-inflammatory and anti-inflammatory mechanisms in diffuse lung disease |
| Q30443091 | The role of CXC chemokines in pulmonary fibrosis |
| Q38181043 | Vascular remodelling in the pathogenesis of idiopathic pulmonary fibrosis. |
Search more.